GlaxoSmithKline said Wednesday a Senate report criticizing its handling of heart risks with its diabetes drug Avandia "mischaracterizes and distorts" the company's record. In a memo posted online, the British drugmaker takes aim at the highly critical Senate Finance Committee report that has reignited ...

London's FTSE 100 rose at the open on Tuesday, gaining 0.49 percent to 5,378.43 points. The index of leading shares had on Monday shed 0.11 percent to close at 5,352.07. Monday's gains in the mining sector had been offset by losses sustained by pharmaceutical giant GlaxoSmithKline (GSK) after concern over its diabetes ...

WASHINGTON (Reuters) - Two U.S. drug safety reviewers have recommended that GlaxoSmithKline PLC's diabetes drug Avandia be pulled from the market after concluding it is more dangerous to the heart than a rival medicine, according to documents released on Saturday. The Food and Drug Administration will again ask an advisory panel to consider the risks of the drug, Glaxo ...